Merrimack Pharmaceuticals logo

Merrimack PharmaceuticalsNASDAQ: MACK

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

29 March 2012

Next earnings report:

02 August 2024

Last dividends:

09 May 2024

Next dividends:

N/A
$223.75 M
0%vs. 3y high
56%vs. sector
0%vs. 3y high
3%vs. sector
-92%vs. 3y high
40%vs. sector
-vs. 3y high
-vs. sector

Price

regular market | Thu, 23 May 2024 13:30:00 GMT
$15.13(0.00%)
No data over the past 3 years

Analysts recommendations

Institutional Ownership

Included in screeners

No data

What type of business is Merrimack Pharmaceuticals?

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

What sector is Merrimack Pharmaceuticals in?

Merrimack Pharmaceuticals is in the Healthcare sector

What industry is Merrimack Pharmaceuticals in?

Merrimack Pharmaceuticals is in the Biotechnology industry

What country is Merrimack Pharmaceuticals from?

Merrimack Pharmaceuticals is headquartered in United States

When did Merrimack Pharmaceuticals go public?

Merrimack Pharmaceuticals initial public offering (IPO) was on 29 March 2012

What is Merrimack Pharmaceuticals website?

https://www.merrimack.com

Is Merrimack Pharmaceuticals in the S&P 500?

No, Merrimack Pharmaceuticals is not included in the S&P 500 index

Is Merrimack Pharmaceuticals in the NASDAQ 100?

No, Merrimack Pharmaceuticals is not included in the NASDAQ 100 index

Is Merrimack Pharmaceuticals in the Dow Jones?

No, Merrimack Pharmaceuticals is not included in the Dow Jones index

When does Merrimack Pharmaceuticals report earnings?

The next expected earnings date for Merrimack Pharmaceuticals is 02 August 2024